The lead discovery process in drug design is essential for B. Pharm students, covering strategies to identify and optimize chemical entities into viable drug candidates. This topic includes target validation, high-throughput screening (HTS), fragment-based and structure-based drug design, virtual screening, and ligand-based approaches. Core concepts such as hit-to-lead progression, lead optimization, SAR, QSAR, ADMET profiling, pharmacokinetics, potency, selectivity, and cheminformatics are emphasized. Practical techniques like docking, pharmacophore modelling, combinatorial chemistry, and bioassay design help predict and improve drug-like properties. These MCQs focus on practical concepts, examples, and exam-style questions relevant to the pharmacy curriculum.
Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary goal of the lead discovery process in drug design?
- To synthesize the final marketed drug
- To identify and optimize chemical entities as drug leads
- To conduct clinical trials directly on targets
- To produce generic versions of existing drugs
Correct Answer: To identify and optimize chemical entities as drug leads
Q2. Which technique is commonly used for screening large compound libraries rapidly?
- Fragment-based screening
- High-throughput screening (HTS)
- ADMET profiling
- Lead optimization
Correct Answer: High-throughput screening (HTS)
Q3. Fragment-based lead discovery primarily uses which approach?
- Screening large drug-like molecules only
- Screening small low-molecular-weight fragments and growing them
- Only using in vivo animal models
- Targeting mRNA transcripts directly
Correct Answer: Screening small low-molecular-weight fragments and growing them
Q4. Structure-based drug design (SBDD) relies mainly on:
- Patient epidemiology data
- Three-dimensional structure of the biological target
- Chemical synthesis yield optimization
- Pharmacovigilance databases
Correct Answer: Three-dimensional structure of the biological target
Q5. Ligand-based drug design is most useful when:
- No active ligands are known for the target
- The target crystal structure is unavailable but known active ligands exist
- Only genomic data is available
- Clinical trial data is complete
Correct Answer: The target crystal structure is unavailable but known active ligands exist
Q6. Hit-to-lead (H2L) stage focuses on:
- Large-scale marketing of hits
- Converting initial hits into optimized leads with improved properties
- Performing phase III clinical trials
- Patent filing for every hit
Correct Answer: Converting initial hits into optimized leads with improved properties
Q7. Which parameter measures the concentration of a drug giving half-maximal response?
- Ki
- Kd
- IC50
- LogP
Correct Answer: IC50
Q8. Lipinski’s Rule of Five is used to predict:
- Antigenicity of a peptide
- Drug-likeness and oral bioavailability
- Toxicity in liver microsomes
- Protein tertiary structure
Correct Answer: Drug-likeness and oral bioavailability
Q9. QSAR models correlate chemical structure with:
- Experimental assay throughput
- Biological activity or physicochemical properties
- Market demand for the drug
- Patent lifespan
Correct Answer: Biological activity or physicochemical properties
Q10. ADMET profiling includes assessment of:
- Absorption, distribution, metabolism, excretion, and toxicity
- Analytical method development only
- Only drug-target binding kinetics
- Clinical trial enrollment criteria
Correct Answer: Absorption, distribution, metabolism, excretion, and toxicity
Q11. Which computational method predicts how a small molecule fits into a binding site?
- Pharmacokinetic modeling
- Docking
- High-content screening
- Chromatography
Correct Answer: Docking
Q12. A pharmacophore model represents:
- The full 3D structure of the protein target
- Essential steric and electronic features required for activity
- Only the ADMET properties of a drug
- A list of marketed drugs
Correct Answer: Essential steric and electronic features required for activity
Q13. Hit rate in a screening campaign refers to:
- Proportion of compounds that show desired activity
- Number of assays performed per day
- Percentage of compounds that pass toxicology
- Ratio of in vivo to in vitro tests
Correct Answer: Proportion of compounds that show desired activity
Q14. Fragment growing differs from fragment linking by:
- Growing adds atoms to a fragment while linking connects two fragments
- Both are identical strategies
- Linking adds atoms while growing connects fragments
- Neither uses structural information
Correct Answer: Growing adds atoms to a fragment while linking connects two fragments
Q15. Which assay type provides information about mechanism and off-target effects?
- Biochemical target-based assay only
- Cell-based assays and high-content screening
- Solubility testing only
- Simple colorimetric assays without cells
Correct Answer: Cell-based assays and high-content screening
Q16. Selectivity of a lead compound refers to:
- Ability to be absorbed in the gut
- Preferential activity on the intended target over other targets
- How quickly it is metabolized
- Its crystallinity for formulation
Correct Answer: Preferential activity on the intended target over other targets
Q17. Which metric describes equilibrium binding affinity between ligand and target?
- IC50
- Kd
- LogP
- pKa
Correct Answer: Kd
Q18. Scaffold hopping is a strategy to:
- Increase the molecular weight of leads
- Replace core structures to find new chemotypes with similar activity
- Only improve solubility without affecting potency
- Convert small molecules into biologics
Correct Answer: Replace core structures to find new chemotypes with similar activity
Q19. In silico ADMET prediction helps by:
- Replacing all wet-lab toxicology studies
- Prioritizing compounds with favorable predicted properties
- Ensuring 100% clinical success
- Predicting exact human clearance values
Correct Answer: Prioritizing compounds with favorable predicted properties
Q20. A low micromolar IC50 value generally indicates:
- Very weak activity
- Moderate to good potency depending on context
- Absolute safety in humans
- High metabolic stability always
Correct Answer: Moderate to good potency depending on context
Q21. Which property is commonly reduced during lead optimization to improve bioavailability?
- Water solubility
- Polar surface area when excessive
- Binding affinity
- Thermal stability
Correct Answer: Polar surface area when excessive
Q22. Combinatorial chemistry primarily enables:
- Rapid synthesis of diverse compound libraries
- Only structure-based design
- Direct clinical testing
- Exclusive use of natural products
Correct Answer: Rapid synthesis of diverse compound libraries
Q23. Lead-like properties differ from drug-like properties by usually being:
- Larger and more lipophilic than drugs
- Smaller and simpler to allow optimization
- Already approved by regulatory agencies
- Identical to final marketed drugs
Correct Answer: Smaller and simpler to allow optimization
Q24. A high-throughput screen produces many false positives; which follow-up reduces these?
- Primary screen repetition without change
- Counter-screening and orthogonal assays
- Immediate animal testing
- Skipping hit validation
Correct Answer: Counter-screening and orthogonal assays
Q25. Which descriptor estimates lipophilicity important for ADME?
- IC50
- LogP
- pH
- Melting point
Correct Answer: LogP
Q26. Target validation in lead discovery ensures:
- The target is essential and modulating it produces desired effect
- The target has been patented already
- Only that a ligand binds in vitro
- Drug manufacturing feasibility
Correct Answer: The target is essential and modulating it produces desired effect
Q27. Which technique maps essential interactions of known ligands to build virtual models?
- Pharmacophore modelling
- Mass spectrometry
- Western blotting
- Gas chromatography
Correct Answer: Pharmacophore modelling
Q28. In lead optimization, improving metabolic stability often targets:
- Reducing sites of metabolic vulnerability
- Increasing overall polarity dramatically
- Adding multiple metabolically labile groups
- Eliminating all hydrogen donors
Correct Answer: Reducing sites of metabolic vulnerability
Q29. Which outcome indicates a successful hit-to-lead campaign?
- Identification of a lead with improved potency, selectivity, and ADMET profile
- Only finding one more structurally similar compound
- Immediate regulatory approval
- Failure to reproduce initial activity
Correct Answer: Identification of a lead with improved potency, selectivity, and ADMET profile
Q30. Cheminformatics in lead discovery is primarily used to:
- Store and analyze chemical and biological data to support decision-making
- Perform only clinical pharmacology
- Manufacture bulk drug substance
- Replace wet-lab assays completely
Correct Answer: Store and analyze chemical and biological data to support decision-making
